Heart Transplant
Pipeline by Development Stage
On Market (1)
Approved therapies currently available
Competitive Landscape
6 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Showing 15 of 50 trials with date data
Clinical Trials (50)
Total enrollment: 104,184 patients across 50 trials
Optimize Immunosuppressive Therapy Using Everolimus and Low-dose Calcineurin Inhibitors in Heart Transplant Patients in Korea
Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver Transplant
Stress Cardiac MRI for Evaluation of Nonspecific Allograft Dysfunction
Prevention of RSV Infections in Bone Marrow Transplant Recipients
An Evaluation of IV Gamma Globulin As a Method to Improve Kidney Transplant Survival in Patients With End-Stage Renal Disease Who Are Highly Sensitized to Transplant Antigens
Prevention of Kidney Transplant Rejection
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
Efficacy of Islet After Kidney Transplantation
Treatment of Chronic Granulomatous Disease With Allogeneic Stem Cell Transplantation Versus Standard of Care
A Study To Test An Anti-Rejection Therapy After Kidney Transplantation
Ribavirin to Prevent RSV Pneumonia in Bone Marrow Transplant Patients
Belatacept in Heart Transplantation
Expanding Liver Transplant Immunosuppression Minimization Via Everolimus
Advancing Transplantation Outcomes in Children
Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation
COVID-19 Protection After Transplant Pilot Study
Safety and Efficacy of Desensitization Therapy in Sensitized Participants Awaiting Heart Transplantation
Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients
Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation
Strategies to Improve Islet Survival
Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases
Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients
Thymus Transplantation Dose in DiGeorge #932
Improving Transplant Options of Highly Sensitized Recipients Using IGIV-C, 10%
Stem Cell Transplantation to Treat Leukocyte Adhesion Deficiency
Stem Cell Transplantation After Reduced-Dose Chemotherapy for Patients With Sickle Cell Disease or Thalassemia
Modified Stem Cell Transplantation Procedure for Treating Chronic Granulomatous Disease
Fecal Microbiota Transplantation for Chronic Granulomatous Disease-Associated Colitis
Bilateral Orthotopic Lung Transplant - Bone Marrow Transplant
Treg Therapy in Subclinical Inflammation in Kidney Transplantation
Allogeneic Hematopoietic Cell Transplantation for Severe Systemic Sclerosis
Omega-3 Fatty Acids That Affect the Immune System in Kidney Transplant Patients
EVR and EPO for Liver Transplant Tolerance
Subcutaneous Abatacept in Renal Transplant Recipients
Study to Assess the Use of JSP191 in Matched Unrelated Donor Transplantation for Chronic Granulomatous Disease (CGD)
Research Study of ATG and Rituximab in Renal Transplantation
Safety of Immunosuppression Minimization in Children and Adolescents After Kidney Transplantation
Donor Stem Cell Transplantation for Congenital Immunodeficiencies
Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients
Parathyroid and Thymus Transplantation in DiGeorge #931
Use of Busulfan as Conditioning Agent for a Second Stem Cell Transplant
Combined Bone Marrow and Kidney Transplant for Multiple Myeloma With Kidney Failure
Reducing the Risk of Transplant Rejection: Simultaneous Kidney and Bone Marrow Transplant
Thymus Transplantation With Immunosuppression
Stem Cell Transplant Following Low-Intensity Chemotherapy to Treat Chronic Granulomatous Disease
Enhancing Heart Allograft Function With the OCS Heart System Trial
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)
Fecal Microbiota Transplant National Registry
US National OCS Heart Perfusion (OHP) Registry
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.